Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b study / Ottmann Oliver, G.; Stegelmann, Frank; Breccia, Massimo; Steegmann Juan, Luis; Olavarria, Eduardo; Aimone, Paola; Lipton Jeffrey, H.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - 62:3(2021), pp. 739-742. [10.1080/10428194.2020.1839649]
Smoothened inhibitor erismodegib combined with nilotinib in patients with chronic myeloid leukemia resistant/intolerant to at least one prior tyrosine kinase inhibitor: a phase 1b study
Breccia Massimo;
2021
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
